PLITICAN, solution for injection 6 ampoules of 2 ml
Active ingredients: Alizapride, Alizapride hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection6 ampoules of 2 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PLITICAN, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 6 ampoule(s) de 2 ml
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68650684CIP73224148CIP133400932241484Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALIZAPRIDE (CHLORHYDRATE D')solution | — | SA |
| ALIZAPRIDEsolution | 50 mg · une ampoule de 2 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.